Table I.
Association between miR-3666 expression and clinicopathological features of patients with CRC.
| Features | Cases | Low expression | High expression | P-value |
|---|---|---|---|---|
| Sex | 0.414 | |||
| Male | 28 | 12 | 16 | |
| Female | 25 | 14 | 11 | |
| Age (years) | 0.275 | |||
| <60 | 30 | 16 | 15 | |
| ≥60 | 23 | 10 | 12 | |
| Tumor size (cm) | 0.028a | |||
| <5 | 25 | 8 | 17 | |
| ≥5 | 28 | 18 | 10 | |
| Lymph node metastasis | 0.028a | |||
| Absent | 29 | 10 | 19 | |
| Present | 24 | 16 | 8 | |
| TNM stage | 0.006a | |||
| I–II | 25 | 7 | 18 | |
| III–IV | 28 | 19 | 9 |
The association between miR-3666 levels and the clinical features of patients with CRC was analyzed using the Chi-square test.
a
P<0.05 was considered to represent a statistically significant difference. CRC, colorectal cancer; miR, microRNA; TNM, tumor, node and metastasis.